Production (Stage)
Pasithea Therapeutics Corp.
KTTA
$0.69
$0.00070.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.44% | 22.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.88% | 8.49% | |||
| Operating Income | -12.88% | -8.49% | |||
| Income Before Tax | -12.13% | -5.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.13% | -5.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.13% | -5.93% | |||
| EBIT | -12.88% | -8.49% | |||
| EBITDA | -13.58% | -8.97% | |||
| EPS Basic | 36.39% | 11.83% | |||
| Normalized Basic EPS | 36.40% | 11.82% | |||
| EPS Diluted | 36.39% | 11.83% | |||
| Normalized Diluted EPS | 36.40% | 11.82% | |||
| Average Basic Shares Outstanding | 76.28% | 20.14% | |||
| Average Diluted Shares Outstanding | 76.28% | 20.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||